The Bioinventors Podcast

Send us Fan Mail

This is our 2nd episode with RJ. As the co-founder of Estenda Solutions, Richard brings a wealth of experience in digital health innovation. Estenda specializes in custom software design, development, data analytics, and AI/ML, partnering with commercial and research organizations to create impactful solutions for patient and population health. In his role as COO/CTO and Digital Health Solution Architect, Richard is at the forefront of healthcare technology advancements.

Topics covered:

Tech in Healthcare: A success story demonstrating technology’s positive impact on patient outcomes.

Challenges in Healthcare: Regulatory, ethical, and patient-centered complexities make healthcare unique and challenging.

AI/ML in Digital Health: Predictions on AI’s role in diagnostics and personalized medicine in the next decade.

Advice for Biology Students: Guidance on exploring computational biology and technology-aligned careers.

Computational Biology’s Impact: Its potential for scientific breakthroughs and economic growth.

Tips for Young CEOs and Scientists: Essential skills like statistics, adaptability, and ethical awareness to thrive in biotech and digital health.


LinkedIn: https://www.linkedin.com/in/rjkedziora
Estenda Inc: https://estenda.com/

Support the show

Send us Fan Mail

In this episode of Biotech LifeStream, we’re honored to welcome Dr. Michael J. Hession, a seasoned physician with over three decades of experience and a distinguished graduate of Dartmouth Medical School. While his professional credentials are remarkable, it’s his profound personal journey that truly sets him apart. On December 31, 2013, Dr. Hession faced a near-death experience that dramatically transformed his perspective on both life and medicine—this pivotal moment, followed by a lengthy and challenging recovery, gifted him with a unique understanding of resilience and the power of the human spirit.

Dr. Hession shares his deeply personal story in his memoir, Physician Heal Thyself, exploring what it means to confront mortality, navigate the arduous path to recovery, and discover a renewed sense of purpose. In our conversation, he brings together his medical expertise and personal insights, providing invaluable wisdom on the complexities of recovery and healing. Join us for an inspiring discussion on resilience, personal growth, and the courage it takes to find strength in life’s most significant challenges. Dr. Hession’s story is a testament to the transformative power of adversity, making this episode a must-listen for anyone seeking insight into facing life’s struggles with hope and determination.

Questions asked: 


- Can you tell us about your medical journey, from how your passion for medicine developed to your experience at Dartmouth Medical School? 

- How did your medical background influence your ability to understand and cope with your own treatment?

- Given your deep experience with medicine, how do you think biotechnology could evolve to better support patients going through similarly critical or life-threatening situations?

- Did your medical practice change in any specific way after your recovery, especially in how you interact with patients and their families?

- In your experience, did you see any gaps in the current medical system where biotechnology could have made a difference? For instance, in terms of diagnostics, treatment personalization, or post-treatment care?

- What biotech advancement, if more prevalent during your illness, would have made your recovery experience better?

- What advice would you give to the next generation of doctors and scientists? 

Facebook: https://www.facebook.com/profile.php?id=61560101224931

Support the show

Send us Fan Mail

In this episode of Biotech LifeStream, we welcome Douglas Mulhall, a pioneering author and researcher whose groundbreaking work on longevity reshapes how we think about heart and body health. His book, Discovering the Nature of Longevity: Restoring the Heart and Body by Targeting Hidden Stress, features a foreword by Columbia University’s Chief of Cardiology and is endorsed by the American Institute of Stress. Douglas' vast expertise spans biotech innovation, heart disease therapies, and longevity research, making him a leading voice in the intersection of health and advanced science. Tune in for an insightful discussion on the future of wellness and the science behind restoring vitality.

Website: https://www.natureoflongevity.com/

book: https://www.amazon.com/dp/1738926737?ref_=cm_sw_r_cp_ud_dp_60JDHFZ9YWCFRVFV5635

Elastrin Therapeutics: https://www.elastrin.com/

Support the show

Send us Fan Mail

In this episode of Biotech LifeStream, we are joined by with Mark Young, a seasoned entrepreneur and the driving force behind Zona Health’s innovative approach to blood pressure management. With a diverse background in business startups and entrepreneurial ventures, Mark joined Zona Health in 2016 with one goal in mind: to make the Zona Plus a household name. His unique career path, combining experience in compliance, marketing, and scalable growth, has positioned him as a leader in the health tech space.

Mark’s passion for education and delivering practical solutions to consumers is at the heart of his leadership philosophy. He believes that empowering individuals with knowledge is key to engagement, especially in the healthcare sector. Join us as Mark shares his journey, the challenges of bringing the Zona Plus to market, and his vision for the future of drug-free, health-focused solutions.


Episode Notes:

- Introduction to Zona Health and its innovative device, the Zona Plus, which leverages isometric exercise techniques to naturally improve blood pressure.

- Exploration of the science behind isometric exercises and how they stimulate nitric oxide production in the body to regulate blood pressure effectively.

- How Zona Plus fits into the category of biohacking, offering a drug-free, science-backed solution to managing hypertension.

- The origins of this technology, stemming from the discovery of reduced blood pressure in fighter pilots performing isometric exercises, leading to the development of Zona Plus.

- Mark’s journey to becoming the CEO of Zona Health and the challenges he faced in taking the company forward.

- The complexities of marketing a medical device without FDA approval and the obstacles in promoting its benefits to consumers.

- Detailed breakdown of the features and benefits of the Zona Plus, and how it provides a non-invasive, drug-free option for managing blood pressure.

- Future goals for Zona Health, including obtaining FDA approval and advocating for a world where health is managed through exercise and nutrition rather than pharmaceuticals.

- Mark’s advice for students and aspiring biotech entrepreneurs looking to make an impact in the industry.

- A candid discussion on the challenges within the U.S. healthcare system, particularly in relation to accessibility and innovation in medical services.

Links: 

www.zona.com

Support the show

Send us Fan Mail

In this episode of Biotech LifeStream, we are joined by Kristy Lonergan, Senior Director of the adMare Academy, an organization dedicated to cultivating talent and driving growth in the Canadian life sciences industry. Kristy leads the Academy's efforts to train highly-qualified professionals, from undergraduates to senior executives, through innovative programs that help learners develop the knowledge, skills, and networks essential for success in the sector.

As the leader of one of Canada’s most impactful life sciences training initiatives, Kristy shares her insights on how adMare Academy’s unique programs are shaping the future of the industry, fostering the next generation of scientists, entrepreneurs, and executives. Whether you're a student looking to enter the life sciences field or a seasoned professional aiming to advance your career, this conversation will offer valuable perspectives on how to navigate and thrive in the dynamic world of biotechnology.

Episode Note:

• Comprehensive overview of the adMare Academy and the wide range of resources available to individuals looking to build or advance their career in the Canadian life sciences sector.
• A deep dive into the learner experience at the adMare Academy, exploring the unique opportunities and programs designed to foster professional growth at every stage, from undergraduate students to industry executives.
• Kristy Lonergan’s personal journey in the early years of her career, from her undergraduate studies to working in a Winnipeg lab, offering valuable insights into navigating the life sciences landscape.
• A discussion on the intersection of science and business in Canada's thriving life sciences industry, and how the adMare Academy plays a pivotal role in cultivating leadership and entrepreneurial skills.
• How building connections and networking can guide professionals in making strategic career decisions.
• Inspiring stories of entrepreneurship emerging from the adMare Academy’s developmental programs, showcasing the path from science to startup success.
• Exploration of prominent research areas in Canada, including the latest advancements in oncology and neurodegenerative diseases.
• Kristy’s advice for aspiring biotech students and future CEOs on how to break into the industry and chart a successful career path.

Support the show

Send us Fan Mail

Ashley is the CEO and founder of Torigen Pharmaceuticals, a company born out of her graduate thesis at the University of Notre Dame. She holds a degree in Pathobiology from the University of Connecticut (2012) and completed her Master’s at Notre Dame in 2013. Torigen focuses on an experimental autologous cancer vaccine developed from the research of Dr. Mark Suckow, one of her professors at Notre Dame.

Ashley has received several prestigious accolades, including being named to Forbes 30 Under 30 in 2020, the Animal Health Innovation USA Award in 2021, Notre Dame’s Domer Dozen in 2021, and the Hartford Business Journal’s 2023 Power 50 list.

EPISODE SUMMARY: 

She talked about how her passion for oncology developed, how she pursued that passion, and how she found opportunities in college.

How she transitions from a research environment to a business environment 

Taking a business path in personalized vaccines and finding the goal of Torigen Pharmaceuticals.

Torigen Pharmaceuticals and producing cancer vaccines for dogs

Personalized cancer vaccine.

Biggest problem with treating animals with cancer therapy vaccine 

How she connected with colleagues and professors

Advice to establishing connections  

The potential in microbiome for therapeutics  

Antigen T-cells binding epitopes as a potential research topic.  

Advice for future passionate students    

Visible software for connections 

email: [email protected]

Website: www.torigen.com


 

Support the show

Send us Fan Mail

As the co-founder of Estenda Solutions, Richard brings a wealth of experience in digital health innovation. Estenda specializes in custom software design, development, data analytics, and AI/ML, partnering with commercial and research organizations to create impactful solutions for patient and population health. In his role as COO/CTO and Digital Health Solution Architect, Richard is at the forefront of healthcare technology advancements.

Topics:

Estenda’s Work: The company focuses on developing machine learning techniques, such as those used for detecting diabetic retinopathy, and on early projects like diabetes disease management for the military and veterans.

Pivotal Moments: Richard reflects on key projects that shaped his career and led to the founding of Estenda Solutions. He discusses adapting to significant changes in the industry, especially around medical data, privacy regulations, and navigating the FDA process.

Industry Shifts: It is essential to understand that “data is the new oil” and how Estenda has embraced this concept to stay ahead in the evolving digital health landscape.

Current Trends: The future of personalized treatments using AI companions, integrating daily life activities and health data, and how these innovations can improve patient care and outcomes.

Advice for Students: Richard encourages younger generations to explore tools like ChatGPT while emphasizing the critical importance of data analysis and understanding statistics.

Research paper discussed:

https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2814752

Link:

https://www.estenda.com

Support the show

Send us Fan Mail

The guest for today's episode is Tom Paladino, whose journey into Scalar Light research began during his undergraduate years. Inspired by scientists like Nikola Tesla, the genius behind alternating current, Tom became intrigued by the possibility of an energy source outside the electromagnetic spectrum. Determined to explore this emerging science, which isn't taught at the university level, he pursued independent study to deepen his understanding and eventually harness Scalar Light.

Tom followed in the footsteps of Dr. T. Galen Hieronymus, one of the few Scalar Light researchers in the U.S. over the past century. After Galen’s passing, Tom had the unique opportunity to read his notes and use his Scalar Light instruments. This hands-on experience further fueled his conviction that Scalar Light technology holds great potential to improve human welfare.

Building on Hieronymus' discoveries, Tom engineered Scalar Light instruments that can harness and transmit Scalar Light to the photographic force fields of people, animals, plants, and objects. These perfected instruments can now identify and neutralize the molecular intelligence of pathogens found in photographs, including over 400,000 species of viruses, bacteria, fungi, and protozoa. Through his ongoing Scalar Light research and practice, Tom envisions a future where humanity can achieve excellent health.

In this episode:

- Tom's initiative for Scalar Light

- roles and goals of scalar light

- advice for younger generations who want to be in Tom's position? What qualities should a healthcare-related CEO have?

- The game-changing research topic that future students /researchers can pursue

and much more!


www.scalarlight.com

Support the show

Send us Fan Mail

Author Laura Johnson Dahlke is a writer and scholar who is passionate about topics related to pregnancy, childbirth, and reproductive technologies. In her work, she synthesizes complex ideas from various disciplines—such as medical science, philosophy, literature, and psychology—with clarity and readability.

In this episode:

- Daily life and how that contributes to her career
- What is ectogenesis, what questions does it raise
- The current state of artificial womb technology
- How can this technology help the declining birth rate?
- What is one of the biggest hurdles in learning and writing about ectogenesis?
- Advice for students

Website: https://www.laurajohnsondahlke.com/

Support the show

Send us Fan Mail

Terry brings over 25 years of experience in information security, covering everything from technical aspects to compliance and executive leadership. He spent a decade as an Information Security Officer for major U.S. healthcare organizations, including as VP of Cybersecurity at Atrium Health. 

In this episode, we cover:

1. What are cyber security executive, and what are their responsibilities 
2. How did his passion for cybersecurity happen
3. Risk- management in each business 
4. biggest cybersecurity issue in healthcare companies (inventory, structure ) 
5. big vs. small companies' cybersecurity manner
6. impact of AI and AI risk management 
7. advice for people who are interested in cybersecurity 
8. Advice for future CEOs
   
   
   

Support the show